Crossref
Removing the signal is not correcting the imbalance: sFlt-1–depletion trials in preeclampsia need fetal as well as maternal endpoints
Pregnancy Hypertension · 2026-12 · 46 · 101545
DOI: 10.1016/j.preghy.2026.101545 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pregnancy Hypertension, 2026-12. Verfasst von Maria Cezara Mureșan und 1 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mureșan, M. C., & Mureșan, M. B. (2026). Removing the signal is not correcting the imbalance: sFlt-1–depletion trials in preeclampsia need fetal as well as maternal endpoints. Pregnancy Hypertension, 46, 101545. https://doi.org/10.1016/j.preghy.2026.101545
Vancouver
Mureșan MC, Mureșan MB. Removing the signal is not correcting the imbalance: sFlt-1–depletion trials in preeclampsia need fetal as well as maternal endpoints. Pregnancy Hypertension. 2026;46:101545. doi:10.1016/j.preghy.2026.101545
BibTeX
@article{Murean2026,
author = {Mureșan, Maria Cezara and Mureșan, Marius Bogdan},
title = {Removing the signal is not correcting the imbalance: sFlt-1–depletion trials in preeclampsia need fetal as well as maternal endpoints},
journal = {Pregnancy Hypertension},
year = {2026},
volume = {46},
pages = {101545},
doi = {10.1016/j.preghy.2026.101545}
}
EUVIMED